Reducing plasmodium falciparum malaria transmission in Africa : a model-based evaluation of intervention strategies

[thumbnail of WRAP_Hollingsworth_Reducing_journal.pmed.1000324.pdf]
Preview
Text
WRAP_Hollingsworth_Reducing_journal.pmed.1000324.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike .

Download (1MB) | Preview

Request Changes to record.

Abstract

Background:
Over the past decade malaria intervention coverage has been scaled up across Africa. However, it remains unclear what overall reduction in transmission is achievable using currently available tools.
Methods and Findings:
We developed an individual-based simulation model for Plasmodium falciparum transmission in an African context incorporating the three major vector species (Anopheles gambiae s.s., An. arabiensis, and An. funestus) with parameters obtained by fitting to parasite prevalence data from 34 transmission settings across Africa. We incorporated the effect of the switch to artemisinin-combination therapy (ACT) and increasing coverage of long-lasting insecticide treated nets (LLINs) from the year 2000 onwards. We then explored the impact on transmission of continued roll-out of LLINs, additional rounds of indoor residual spraying (IRS), mass screening and treatment (MSAT), and a future RTS,S/AS01 vaccine in six representative settings with varying transmission intensity (as summarized by the annual entomological inoculation rate, EIR: 1 setting with low, 3 with moderate, and 2 with high EIRs), vector–species combinations, and patterns of seasonality. In all settings we considered a realistic target of 80% coverage of interventions. In the low-transmission setting (EIR~3 ibppy [infectious bites per person per year]), LLINs have the potential to reduce malaria transmission to low levels (<1% parasite prevalence in all age-groups) provided usage levels are high and sustained. In two of the moderate-transmission settings (EIR~43 and 81 ibppy), additional rounds of IRS with DDT coupled with MSAT could drive parasite prevalence below a 1% threshold. However, in the third (EIR = 46) with An. arabiensis prevailing, these interventions are insufficient to reach this threshold. In both high-transmission settings (EIR~586 and 675 ibppy), either unrealistically high coverage levels (>90%) or novel tools and/or substantial social improvements will be required, although considerable reductions in prevalence can be achieved with existing tools and realistic coverage levels.
Conclusions:
Interventions using current tools can result in major reductions in P. falciparum malaria transmission and the associated disease burden in Africa. Reduction to the 1% parasite prevalence threshold is possible in low- to moderate-transmission settings when vectors are primarily endophilic (indoor-resting), provided a comprehensive and sustained intervention program is achieved through roll-out of interventions. In high-transmission settings and those in which vectors are mainly exophilic (outdoor-resting), additional new tools that target exophagic (outdoor-biting), exophilic, and partly zoophagic mosquitoes will be required.

Item Type: Journal Article
Subjects: R Medicine > RA Public aspects of medicine
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- )
Faculty of Science, Engineering and Medicine > Science > Mathematics
Library of Congress Subject Headings (LCSH): Malaria, Malaria -- Prevention, Malariotherapy, Malaria -- Research
Journal or Publication Title: PLoS Medicine
Publisher: PLOS
ISSN: 1549-1676
Official Date: 2010
Dates:
Date
Event
2010
Published
Volume: Volume 7
Number: Number 8
Page Range: Article no. e1000324
DOI: 10.1371/journal.pmed.1000324
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons open licence)
Date of first compliant deposit: 23 December 2015
Date of first compliant Open Access: 23 December 2015
Funder: Bill & Melinda Gates Foundation, Medical Research Council (Great Britain) (MRC), Microsoft Research, Seventh Framework Programme (European Commission) (FP7), Imperial College, London
Grant number: HEALTH-F3-2008-223736 (FP7)
URI: https://wrap.warwick.ac.uk/51879/

Export / Share Citation


Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item